002173.SZ
创新医疗
SZSE · Consumer Cyclical · Q 卫生 · CN
CNY 17.67
−3.60%Year over year
Reported trailing growth
- Revenue
- -6.6%
- EBITDA
- —
- EBIT
- +39.9%
- EPS
- +53.4%
- Free cash flow
- +116.4%
- Operating cash flow
- +349.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +3.3%
- EBITDA
- +28.8%
- EBIT
- +49.3%
- Net income
- +62.9%
- EPS
- +61.9%
- Free cash flow
- +84.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026